Prosecution Insights
Prosecution Insights
6 pending office actions • 5 art units • 5 examiners • 0 of 6 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 6 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 6 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 4 (67%) |
| §102 only | 1 (17%) |
| §112 only | 1 (17%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GERIDO, DWAN A | 2 | 57.7% | +30.9% |
| LEE, JAE W | 1 | 65.6% | +38.6% |
| EDMONDSON, LYNNE RENEE | 1 | 71.1% | +15.6% |
| BAUER, NICOLA MARIA | 1 | 59.6% | +41.8% |
| LI, RUIXIANG | 1 | 59.4% | +19.0% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17487164 | NANOPORES WITH INTERNAL PROTEIN ADAPTORS | LI, RUIXIANG | 9d overdue |
| 17783671 | COMPOUNDS FOR TREATMENT OF ALZHEIMER'S DISEASE | BAUER, NICOLA MARIA | 5d |
| 17801651 | COLLOIDAL NANOPARTICLE INKS FOR PRINTING OF ACTIVE LAYERS IN AN OPTOELECTRONIC DEVICE | EDMONDSON, LYNNE RENEE | 7d |
| 18394833 | ARTIFICIAL NANOPORES AND USES AND METHODS RELATING THERETO | GERIDO, DWAN A | 14d |
| 17777757 | Artificial nanopores and uses and methods relating thereto | GERIDO, DWAN A | 23d |
| 17905911 | Engineered PlyAB Nanopores and Uses Thereof | LEE, JAE W | 33d |
| Art Unit | Apps |
|---|---|
| 1797 | 2 |
| 1656 | 1 |
| 1734 | 1 |
| 1621 | 1 |
| 1674 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18394833 | ARTIFICIAL NANOPORES AND USES AND METHODS RELATING THERETO | GERIDO, DWAN A | 1797 | §103 | Final Rejection | 14d | Pending | Dec 22, 2023 |
| 17905911 | Engineered PlyAB Nanopores and Uses Thereof | LEE, JAE W | 1656 | §102 | Non-Final OA | 33d | Pending | Sep 08, 2022 |
| 17801651 | COLLOIDAL NANOPARTICLE INKS FOR PRINTING OF ACTIVE LAYERS IN AN OPTOELECTRONIC DEVICE | EDMONDSON, LYNNE RENEE | 1734 | §103 | Non-Final OA | 7d | Pending | Aug 23, 2022 |
| 17783671 | COMPOUNDS FOR TREATMENT OF ALZHEIMER'S DISEASE | BAUER, NICOLA MARIA | 1621 | §103 | Final Rejection | 5d | Pending | Jun 09, 2022 |
| 17777757 | Artificial nanopores and uses and methods relating thereto | GERIDO, DWAN A | 1797 | §103 | Final Rejection | 23d | Pending | May 18, 2022 |
| 17487164 | NANOPORES WITH INTERNAL PROTEIN ADAPTORS | LI, RUIXIANG | 1674 | §112 | Final Rejection | 9d overdue | Pending | Sep 28, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial